Preparation and Characterization of Liposomal Doxorubicin for Human Use

References

• Liposomes and their uses in biology and medicine. Ann. NY Acad. Sci, D. Papahadjopoulos, 1978; 308
   Google Scholar
• Baldwin T., Howard S. R. Liposomes and Immunobiology. Elsevier, North Holland, Amsterdam 1980
   Google Scholar
• Liposomes: From Physical Structure to Therapeutic Application, C. G. Knight. Elsevier, North Holland, Biomedical Press, Amsterdam 1981
   Google Scholar
• Liposome Technology, G. Gregoriadis. CRC Press, Boca Raton, FL 1984; vol. I, II, III
   Google Scholar
• Medical Application of Liposomes, K. Yogi. Scientific Societies Press, Tokyo 1986
   Google Scholar
• Liposomes—Chemistry and Physics of Lipids, P. R. Cullis, M. J. Hope. Elsevier, ShannonIreland 1986; vol. 40
   Google Scholar
• Liposomes as Drug Carriers, K. H. Schmidt. George Thiem Verlag, Stuttgart 1986
   Google Scholar
• Ostro M. Liposomes: From Biophysics to Therapeutics. Marcel Dekker, Inc., New York 1987
   Google Scholar
• Liposomes as Drug Carriers, G. Gregoriadis. Wiley, New York 1988
   Google Scholar
• Liposomes in the Therapy of Infectious Diseases and Cancer, G. Lopez-Berestein, I. J. Fidler. Alan R. Liss, New York 1989
   Google Scholar
• Gabizon A. Liposomes as a drug delivery system in cancer chemotherapy. Drug Carrier Systems, F. H.D. Roerndik, A. M. Kroon. John Wiley and Sons, New York 1989; 185–211
   Google Scholar
• Poznansky M., Juliano R. L. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol. Rev. 1984; 36: 277–336
   PubMed Web of Science ®Google Scholar
• Rahman A., Kessler A., More N., Sikio B., Rowden G., Woolley P., Schein P. S. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 1980; 40: 1532–1537
   PubMed Web of Science ®Google Scholar
• Rahman A., White G., More N., Schein P. S. Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Cancer Res. 1985; 45: 769–803
   Web of Science ®Google Scholar
• Rahman A., Fumagali A., Barbieri B., Schein P. S., Casazza A. M. Anti-tumor and toxicity evaluation of free doxorubicin and doxuribicin entrapped in cardiolipin liposomes. Cancer Chemother. Pharmacol. 1986; 16: 22–27
   PubMed Web of Science ®Google Scholar
• Forssen E. A., Tokes Z. A. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 1873–1877
   PubMed Web of Science ®Google Scholar
• Forssen E. A., Tokes Z. A. Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes. Cancer Res. 1983; 43: 546–550
   PubMed Web of Science ®Google Scholar
• Olson F., Mayhew E., Maslow D., Rustums Y., Szoka F. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol. 1982; 18: 167–176
   PubMedGoogle Scholar
• Van Hoesel Q. G., Steerenberg P. A., Crommelin D. J., Van Dijk A., Van Oort W., Klein S., Douze J. M., De Wildt D. J., Hillen F. C. Reduced cardiotoxicity and nephrotoxicity with preservation of anti-tumor activity of doxorubicin entrapped in stable liposomes in the Lou/M Wsl rat. Cancer Res. 1984; 44: 3698–3705
   PubMed Web of Science ®Google Scholar
• Gabizon A., Dagan A., Goren D., Barenholz Y., Fuks Z. Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved anti-tumor activity in mice. Cancer Res. 1982; 42: 4734–4739
   PubMed Web of Science ®Google Scholar
• Gabizon A., Goren D., Fuks Z., Barenholz Y., Dagan A., Meshorer A. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Cancer Res. 1983; 43: 4730–4735
   PubMed Web of Science ®Google Scholar
• Gabizon A., Goren D., Fuks Z., Meshorer A., Barenholz Y. Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumor model. Br. J. Cancer 1985; 51: 681–689
   PubMed Web of Science ®Google Scholar
• Gabizon A., Goren D., Ramu A., et al. Design, characterization and anti-tumor activity of adriamycin-containing phospholipids vesicles. Targeting of Drugs with Synthetic Systems, G. Gregoriadis, J. Senior, G. Poste. Plenum Press, London 1986; 229–238
   Google Scholar
• Gabizon A., Meshorer A., Barenholz Y. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J. Natl. Cancer Inst. 1986; 77: 459–469
   PubMed Web of Science ®Google Scholar
• Gabizon A., Sulkes A., Peretz T., Druckman S., Goren D., Amselem S., Barenholz Y. Liposome-associated doxorubicin: Preclinical pharmacology and exploratory clinical phase. Liposomes in the Therapy of Infectious Diseases and Cancer, G. Lopez-Berestein, I. J. Fidler. Alan R. Liss, New York 1988; 391–402
   Google Scholar
• Gabizon A., Peretz T., Sulkes A., Amselem S., Ben-Yosef R., Ben-Baruch N., Catane R., Biran S., Barenholz Y. Systemic administration of doxorubicin-containing liposomes in cancer patients: A phase I study. Eur. J. Cancer Clin. Oncol. 1989; 25: 1795–1803
   PubMedGoogle Scholar
• Gabizon A., Amselem S., Goren D., Cohen R., Druckmann S., Fromer I., Chisin R., Peretz T., Sulkes A., Barenholz Y. Preclinical and clinical experience with a doxorubicin-liposome preparation. J. Liposome Res. 1991; 1: 491–502
   Google Scholar
• Mayhew E., Rustum Y., Vail W. J. Inhibition of liver metastases of M5076 tumor by liposome-entrapped adriamycin. Cancer Drug Deliv. 1983; 1: 43–58
   PubMedGoogle Scholar
• Mayhew E., Rustum Y. The use of liposomes as carriers of therapeutic agents. Molecular Basis of Cancer, Part B: Macro-molecular Recognition, Chemotherapy and Immunology, R. Rein. Alan R. Liss, New York 1985; 301–310
   Google Scholar
• Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M. P., Keating M., Rosenblum M. G., Mehta R., Luna M., Hersh E. M., Reuben J., Juliano R. L., Bodey G. P. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study. J. Infect. Dis. 1985; 151: 704
   PubMed Web of Science ®Google Scholar
• Ostro M. J. Industrial application of liposomes: What does that mean?. Liposomes as Drug Carriers, G. Gregoriadis. Wiley, New York 1988
   Google Scholar
• Lentz B. R., Barenholz Y., Thompson T. E. Fluorescence depolarization studies of phase transitions and fluidity in phospholipid bilayers. I. Single component phosphatidylcholine liposomes. Biochemistry 1976; 15: 4521–4528
   PubMed Web of Science ®Google Scholar
• Yavin E., Zutra A. Separation and analysis of 32P-labeled phospho-lipids by a simple and rapid thin layer chromatographic procedure and its application to cultured neuroblastoma cells. Anal. Biochem. 1977; 80: 430–437
   PubMed Web of Science ®Google Scholar
• Bligh E. J., Dyer W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959; 37: 911–917
   Web of Science ®Google Scholar
• Kates M. Techniques of lipidology. Isolation, analysis and identification of lipids. Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 3, R. M. Burdon, P. M. Van Knippenberg. Elsevier, Amsterdam 1986
   Google Scholar
• Ansari G. A.S., Smith L. L. High performance liquid chromatography of cholesterol autooxidation products. J. Chromatogr. 1979; 175: 307–315
   Web of Science ®Google Scholar
• Smith L. L. Cholesterol Autooxidation. Plenum Press, New York 1981
   Google Scholar
• Korahani V., Basgoul J., de Crastesde Paudet A. Capillary column gas-liquid chromatography analysis of cholesterol derivatives. Application to the autooxidation products of cholesterol. J. Chromatogr. 1981; 211: 382–397
   Web of Science ®Google Scholar
• Bots A. M.B., Van Oort W. J., Noordhdek J., Van Dijk A., Klein S. M. Analysis of adriamycin and adriamycinol in micro volumes of rat plasma. J. Chromatogr. 1983; 272: 421–427
   PubMed Web of Science ®Google Scholar
• Samuni A., Chong P. L.G., Barenholz Y., Thompson T. E. Physical and chemical modifications of adriamycin: iron complex by phospholipid bilayers. Cancer Res 1986; 46: 594–599
   PubMed Web of Science ®Google Scholar
• Beijnen J. Ph.D. Thesis: Chemical stability of mitomycin and anthracycline antineoplastic drugs. Utrecht, The Netherlands 1985
   Google Scholar
• Takanashi S., Bachur N. R. Adriamycin metabolism in man: Evidence from urinary metabolites. Drug. Metabol. Disp. 1976; 4: 79–87
   PubMed Web of Science ®Google Scholar
• Gianni L., Vigano L., Lanzi C., Niggeler M., Malatesta V. Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines. J. Natl. Cancer. Inst. 1988; 80: 1104–1111
   PubMedGoogle Scholar
• Bartlett G. R. Phosphorus assay in column chromatography. J. Biol. Chem. 1959; 234: 466–468
   PubMed Web of Science ®Google Scholar
• Stewart J. C. Colorimetric determination of phospholipids with ammonium ferrothyocyanate. Anal. Biochem. 1980; 104: 10–14
   PubMed Web of Science ®Google Scholar
• Barenholz Y., Patzer E. J., Moore N. F., Wagner R. R. Cholesterol oxidase as a probe for studying membrane composition and organization. Enzymes of Lipid Metabolism, S. Gatt, L. Freysz, P. Mandel. Plenum Publishing Corp., New York 1978; 45–56
   Google Scholar
• Klein R. A. The detection of oxidation in liposome preparations. Biochem. Biophys. Acta 1970; 210: 486–489
   PubMed Web of Science ®Google Scholar
• Lichtenberg D., Barenholz Y. Liposomes: Preparation, Characterization and Preservation. Methods in Biochemical Analysis, Vol. 33, D. Glick. John Wiley and Sons, New York 1988; 337
   Google Scholar
• Sturgeon and Schulman. Electronic absorption spectra and protolytic equilibria of doxorubicin: Direct spectrophotometric determination of microconstants. J. Pharm. Sci. 1977; 66: 958–961
   PubMed Web of Science ®Google Scholar
• Storm G., Van Bloois L., Brouwer M., Crommelin D. J.A. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim. Biophys. Acta 1985; 818: 343–351
   PubMed Web of Science ®Google Scholar
• Amselem S., Gabizon A., Barenholz Y. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J. Pharm. Sci. 1990; 79: 1045–1052
   PubMed Web of Science ®Google Scholar
• Amselem S., Gabizon A., Barenholz Y. Evaluation of a new extrusion device for the production of stable oligolamellar liposomes in a liter-scale. J. Liposome Res. 1990; 1: 287–301
   Google Scholar
• Druckmann S., Gabizon A., Barenholz Y. Sepration of liposome-associated doxorubicin from non-liposomal associated doxorubicin in human plasma: Implications for pharmacokinetic studies. Biochim. Biophys. Acta 1989; 980: 381–384
   PubMed Web of Science ®Google Scholar
• Goormaghtigh E., Ruysschaert J. M. Anthracycline glycoside membrane interactions. Biochim. Biophys. Acta 1984; 779: 279
   Google Scholar
• Goren D., Gabizon A., Barenholz Y. The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. Biochim. Biophys. Acta 1990; 1029: 285–294
   PubMed Web of Science ®Google Scholar
• Nir S., Bentz J., Wilschmt J., Duzgunes N. Aggregation and fusion of phospholipid vesicles. Prog. Surf. Sci. 1983; 13: 1–124
   Web of Science ®Google Scholar
• Gabizon A., Barenholz Y. Adriamycin-containing liposomes in cancer chemotherapy. Liposomes as Drug Carriers, G. Gregoriadis. J. Wiley and Sons, New York 1988; 370
   Google Scholar
• Almog S., Kushnir T., Nir S., Lichtenberg D. Kinetic and structural aspects of reconstitution of phosphatidylcholine vesicles by dilution of phosphatidylcholine-sodium cholate mixed micelles. Biochemistry 1986; 25: 2599–2605
   Web of Science ®Google Scholar
• Ohsawa T., Miura M., Harada K. Improvement of encapsulation efficiency of water-soluble drugs in liposomes formed by the freeze-thawing method. Chem. Pharm. Bull. 1985; 33: 3945–3952
   PubMed Web of Science ®Google Scholar
• Pearson F. C. Pyrogens. Advances in Parenteral Science. Marcel Dekker, New York 1985; 104–118
   Google Scholar